Bimeda announced it has available for sale Bimectin Plus (1% ivermectin and 10% clorsulon) Injection for Cattle.

Bimectin Plus is an injectable parasiticide that is labeled for the treatment and control of internal and external parasites of cattle, including gastrointestinal roundworms, lungworms, sucking lice, mange mites, cattle grubs and adult liver flukes, Bimeda said, adding that Bimectin Plus will provide added protection against the economically damaging liver fluke.

With the approval of Bimectin Plus, Bimeda is expanding its current line of ivermectin-based compounds that include Bimectin Pour-On and Bimectin Injection.

Since its foundation in Ireland in 1961, Bimeda has grown into a leading global manufacturer and distributor of veterinary pharmaceuticals and animal health products. The company, headquartered in Dublin, Ireland, now has a presence in every major animal food producing region in the world. Through ongoing expansion and strategic acquisition, Bimeda has established markets in more than seventy countries worldwide. It is now a successful global organization, with research and development, manufacturing and distribution capabilities across Europe, North America, South America, Africa, the Middle East and Asia.

Bimeda's U.S. headquarters are in Chicago, Ill.